The value of AI for assessing longitudinal brain metastases treatment response.
Saved in:
| Title: | The value of AI for assessing longitudinal brain metastases treatment response. |
|---|---|
| Authors: | Andrearczyk V; Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Institute of Informatics, HES-SO Valais-Wallis University of Applied Sciences and Arts Western Switzerland, Sierre, Switzerland., Schiappacasse L; Lundin Family Brain Tumor Research Centre, Departments of Oncology & Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Radiation Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland., Raccaud M; Department of Medical Radiology, Service of Diagnostic and Interventional Radiology, Neuroradiology Unit, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland., Bourhis J; Lundin Family Brain Tumor Research Centre, Departments of Oncology & Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Radiation Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland., Prior JO; Lundin Family Brain Tumor Research Centre, Departments of Oncology & Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland., Cuendet MA; Lundin Family Brain Tumor Research Centre, Departments of Oncology & Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland., Hottinger AF; Lundin Family Brain Tumor Research Centre, Departments of Oncology & Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland., Dunet V; Lundin Family Brain Tumor Research Centre, Departments of Oncology & Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Medical Radiology, Service of Diagnostic and Interventional Radiology, Neuroradiology Unit, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland., Depeursinge A; Lundin Family Brain Tumor Research Centre, Departments of Oncology & Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Institute of Informatics, HES-SO Valais-Wallis University of Applied Sciences and Arts Western Switzerland, Sierre, Switzerland. |
| Source: | Neuro-oncology advances [Neurooncol Adv] 2025 Jan 10; Vol. 7 (1), pp. vdae216. Date of Electronic Publication: 2025 Jan 10 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39896076 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The value of AI for assessing longitudinal brain metastases treatment response. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Andrearczyk+V%22">Andrearczyk V</searchLink>; Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Institute of Informatics, HES-SO Valais-Wallis University of Applied Sciences and Arts Western Switzerland, Sierre, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schiappacasse+L%22">Schiappacasse L</searchLink>; Lundin Family Brain Tumor Research Centre, Departments of Oncology & Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Radiation Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Raccaud+M%22">Raccaud M</searchLink>; Department of Medical Radiology, Service of Diagnostic and Interventional Radiology, Neuroradiology Unit, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bourhis+J%22">Bourhis J</searchLink>; Lundin Family Brain Tumor Research Centre, Departments of Oncology & Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Radiation Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Prior+JO%22">Prior JO</searchLink>; Lundin Family Brain Tumor Research Centre, Departments of Oncology & Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Cuendet+MA%22">Cuendet MA</searchLink>; Lundin Family Brain Tumor Research Centre, Departments of Oncology & Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Hottinger+AF%22">Hottinger AF</searchLink>; Lundin Family Brain Tumor Research Centre, Departments of Oncology & Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Dunet+V%22">Dunet V</searchLink>; Lundin Family Brain Tumor Research Centre, Departments of Oncology & Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Medical Radiology, Service of Diagnostic and Interventional Radiology, Neuroradiology Unit, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Depeursinge+A%22">Depeursinge A</searchLink>; Lundin Family Brain Tumor Research Centre, Departments of Oncology & Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Institute of Informatics, HES-SO Valais-Wallis University of Applied Sciences and Arts Western Switzerland, Sierre, Switzerland. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101755003%22">Neuro-oncology advances</searchLink> [Neurooncol Adv] 2025 Jan 10; Vol. 7 (1), pp. vdae216. <i>Date of Electronic Publication: </i>2025 Jan 10 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101755003 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2632-2498 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226322498%22">26322498 </searchLink><i>NLM ISO Abbreviation: </i>Neurooncol Adv <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39896076 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/noajnl/vdae216 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: vdae216 Titles: – TitleFull: The value of AI for assessing longitudinal brain metastases treatment response. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Andrearczyk V – PersonEntity: Name: NameFull: Schiappacasse L – PersonEntity: Name: NameFull: Raccaud M – PersonEntity: Name: NameFull: Bourhis J – PersonEntity: Name: NameFull: Prior JO – PersonEntity: Name: NameFull: Cuendet MA – PersonEntity: Name: NameFull: Hottinger AF – PersonEntity: Name: NameFull: Dunet V – PersonEntity: Name: NameFull: Depeursinge A IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 01 Text: 2025 Jan 10 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2632-2498 Numbering: – Type: volume Value: 7 – Type: issue Value: 1 Titles: – TitleFull: Neuro-oncology advances Type: main |
| ResultId | 1 |
